RHY rhythm biosciences limited

0.00%

5.7¢

US based company with better results launching world wide, page-8

First 8 Last

Share
Profile

Follow
ShmoShady

841 Posts.

100

28/12/22

12:24

Post #: 65458530
Share

Originally posted by borano: ↑

You are all a bunch of dreamers!

Let's get one thing straight, I don't dream and/or talk s**t! I don't believe a story that is too good to be true until I do my due diligence.
Once a director/chairman sells a whole heap of shares it should sound alarm bells. Why doesn't someone work out how much that parcel of 5 million shares cost him and what he realised from the sale. Go on, someone do the calculations to confirm my own. He speaks crap about his superfund being overweight. if he really believed in RHY and it was all a no brainer he could have transferred all those shares into his Family Trust.
The value of those shares to him is nothing compared to his wealth.

Most of the directors have shares as part of the float and/or exercising options at very low prices. Someone was saying they have confidence because the directors have shares. Most directors of companies have shares in their company. DYOR. If not I will try and help you out from time to time.

Transformational my ***!

In no particular order.

InterVenn Developing Glycoproteomic Assay for Colorectal Cancer Screening

InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study

Product Pipeline
Differences between IVD tests and LDTs

Applied Proteomics Inc.™ Enters Into Agreement With MultiPlan, Inc. To Provide Reimbursement For Its SimpliPro Colon™ Test

Introducing the SimpliPro Colon ™ Test

Applied Proteomics Sells Assets to DiscernDx for $1.85M

Industry partnership expands access to blood test for colorectal cancer

InterVenn Expands Global Presence to Drive the Potential of Glycoproteomics to Improve Patient Outcomes

I have communicated with specific people but I will not share information that is private, unlike someone on here spruiking the company by copying and pasting questions to the CEO and answers from the CEO. Did you get a kick back?

RHY will get into the market I don't dispute, but they need turn it all into sales and profitability. There is a lot to be done before then. Oh, I forgot, it's all ready to go.........ha ha ha

No doubt you all will say some bull**** to refute what I have posted or said. That's your choice. I'm looking forward to all the negative replies directed at me. Can't wait to be honest.

My sentiment is definitely a SELL now but you all should keep on buying.

Expand

RHY Price at posting: $1.01 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NOX

Noxopharm gets HERACLES autoimmune trials started with first human doses

LDX

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

IMU

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

LIS

Li-S Energy the latest microcap to pivot to US defence market

First 8 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.7¢		Change 0.000(0.00%)		Mkt cap ! $16.19M

Open	High	Low	Value	Volume
5.7¢	6.0¢	5.7¢	$8.485K	144.9K

Buyers (Bids)

No.	Vol.	Price($)
1	2500	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	25000	1

View Market Depth

No.	Vol.	Price($)
1	2500	0.056
1	9734	0.055
2	64727	0.054
2	76690	0.052
4	175097	0.051

Price($)	Vol.	No.
0.059	25000	1
0.060	41316	2
0.061	61771	1
0.062	24978	1
0.063	37527	1

Last trade - 11.21am 16/07/2025 (20 minute delay)

RHY (ASX) Chart

US based company with better results launching world wide, page-8

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Li-S Energy the latest microcap to pivot to US defence market

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

US based company with better results launching world wide, page-8

Top Stories

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Li-S Energy the latest microcap to pivot to US defence market

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News